[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4922 Introduced in House (IH)]

<DOC>






115th CONGRESS
  2d Session
                                H. R. 4922

 To amend the Controlled Substances Act to list fentanyl analogues as 
                   schedule I controlled substances.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            February 5, 2018

Mr. Sensenbrenner introduced the following bill; which was referred to 
the Committee on Energy and Commerce, and in addition to the Committee 
  on the Judiciary, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
 To amend the Controlled Substances Act to list fentanyl analogues as 
                   schedule I controlled substances.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Stopping Overdoses of Fentanyl 
Analogues Act''.

SEC. 2. FENTANYL ANALOGUES.

    Section 202(c) of the Controlled Substances Act (21 U.S.C. 812) is 
amended--
     (a) by adding at the end of subsection (b) of Schedule I the 
following:
            ``(23) Acetyl fentanyl 4-methylphenethyl.
            ``(24) Acrylfentanyl.
            ``(25) 4-fluorobutyrylfentanyl.
            ``(26) 4-fluoroisobutyryl fentanyl.
            ``(27) 3-furanyl fentanyl.
            ``(28) Isobutyryl fentanyl.
            ``(29) Meta-fluorofentanyl.
            ``(30) Methoxyacetyl fentanyl.
            ``(31) 4-methoxybutyrfentanyl.
            ``(32) Ocfentanil.
            ``(33) Ortho-fluorofentanyl.
            ``(34) Tetrahydrofuranyl fentanyl.
            ``(35) Valeryl fentanyl.''; and
    (b) by adding at the end of Schedule I the following:
    ``(e)(1) Unless specifically exempted or unless listed in another 
schedule, any material, compound, mixture, or preparation which 
contains any quantity of fentanyl analogues, or which contains their 
salts, isomers, and salts of isomers whenever the existence of such 
salts, isomers, and salts of isomers is possible within the specific 
chemical designation.
    ``(2) In paragraph (1), the term `fentanyl analogues' includes any 
compound structurally derived from fentanyl--
            ``(A) by replacement of the phenyl portion of the phenethyl 
        group by any monocycle, whether or not further substituted in 
        or on the monocycle;
            ``(B) by substitution in or on the phenethyl group with 
        alkyl, alkenyl, alkoxy, hydroxy, halo, haloalkyl, amino or 
        nitro groups;
            ``(C) by substitution in or on the piperidine ring with 
        alkyl, alkenyl, alkoxy, ester, ether, hydroxy, halo, haloalkyl, 
        amino or nitro groups;
            ``(D) by replacement of the aniline ring with any aromatic 
        monocycle whether or not further substituted in or on the 
        aromatic monocycle; or
            ``(E) by replacement of the N-propionyl group by another 
        acyl group.''.
                                 <all>